Nalaganje...
Individualising Anticoagulant Therapy in Atrial Fibrillation Patients
Non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have emerged as alternatives to VKAs for the prevention of stroke in patients with non-valvular atrial fibrillation. Four NOACS: dabigatran, apixaban, rivaroxaban and edoxaban, have received regulatory approval in Europe from the European Me...
Shranjeno v:
| izdano v: | Arrhythm Electrophysiol Rev |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Radcliffe Cardiology
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013151/ https://ncbi.nlm.nih.gov/pubmed/27617088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/AER.2016.20.3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|